Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

Published:2008-07 Issue:7 Volume:10 Page:545-555
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Chan J. C. N.,Scott R.,Arjona Ferreira J. C.,Sheng D.,Gonzalez E.,Davies M. J.,Stein P. P.,Kaufman K. D.,Amatruda J. M.,Williams-Herman D.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2008.00914.x/fullpdf

Reference25 articles.

1. Screening for Kidney Disease in Adults With Diabetes

2. Diabetic Nephropathy: Diagnosis, Prevention, and Treatment

3. Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin

4. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

5. The biology of incretin hormones

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial;Diabetologia;2024-09-14

2. GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-22

3. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

4. Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin;Diabetes, Obesity and Metabolism;2024-07-11

5. Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM);European Journal of Medicinal Chemistry;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3